Acadia Pharmaceuticals (ACAD) Gross Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7,249.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -191.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -33.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -480.00 |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | -784.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -784.00 |
| Dec 31, 2025 | -747.00 |
| Sep 30, 2025 | -613.00 |
| Jun 30, 2025 | -586.00 |
| Mar 31, 2025 | -579.00 |
| Dec 31, 2024 | -18.00 |
| Sep 30, 2024 | -473.00 |
| Jun 30, 2024 | -534.00 |
| Mar 31, 2024 | -910.00 |
| Dec 31, 2023 | -567.00 |
| Sep 30, 2023 | -524.00 |
| Jun 30, 2023 | -188.00 |
| Mar 31, 2023 | 170.00 |
| Dec 31, 2022 | 130.00 |
| Sep 30, 2022 | 92.00 |
| Jun 30, 2022 | 157.00 |
| Mar 31, 2022 | 213.00 |
| Dec 31, 2021 | -348.00 |
| Sep 30, 2021 | 378.00 |
| Jun 30, 2021 | 405.00 |
| Mar 31, 2021 | 236.00 |
| Dec 31, 2020 | 356.00 |
| Sep 30, 2020 | 434.00 |
| Jun 30, 2020 | 466.00 |
| Mar 31, 2020 | 1,170.00 |
| Dec 31, 2019 | 1,117.00 |
| Sep 30, 2019 | 1,349.00 |
| Jun 30, 2019 | 53,871.00 |